Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06554327 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens

Study acronym: VAMPAIR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 years later Sep 6, 2026 → Sep 6, 2030
See other at-risk trials from CHU de Reims

Record History

  1. Primary completion pushed from Sep 6, 2026 to Sep 6, 2030
    • Study completion pushed from Oct 6, 2026 to Oct 4, 2030
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Feb 2026 to Sep 6, 2026
    • Start date changed from estimate of Sep 2024 to Mar 6, 2025
    • Study completion date: Mar 2026 to Oct 6, 2026
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
CHU de Reims
79 trials monitored
See 2 trials at risk
Ventilator-associated pneumonia (VAP) remains one of the main nosocomial infections acquired in the intensive care unit (ICU). VAP is pneumonia occurring 48 hours after intubation. Today, bronchoalveolar lavage (BAL) is used for microbiological diagnosis, with bacterial culture and antibiotic susceptibility results within 48 to 72 hours. Multiplex PCR can detect DNA of a number of bacteriae, as well as the presence of resistance genes. However, its clinical value in the ICU remains to be demonstrated. We think that the use of multiplex PCR with a panel adapted to the microbiology of VAP, could be an interesting method for clinicians in ICU.
Trial Details
NCT Number NCT06554327
Lead Sponsor CHU de Reims
Conditions
(from sponsor)		 Ventilator Associated Pneumonia
Related terms Disease, Pneumonia, Ventilator-Associated
Enrollment 265 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov